Related Experiment Video
Updated: May 11, 2026
05:07
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Abdominal pain localization is associated with non-diarrheic Rome III functional gastrointestinal disorders
M Bouchoucha1, M Fysekidis, G Devroede
1Service de Physiologie, Université René Descartes, Paris V, Paris, France. michel.bouchoucha@avc.aphp.fr
Neurogastroenterology and Motility
|May 29, 2013
Summary
Functional bowel disorder (FBD) subtypes show distinct abdominal pain locations. Identifying these pain sites can help classify non-diarrheic functional bowel disorders.
Area of Science:
- Gastroenterology
- Functional Bowel Disorders Research
- Pain Localization Studies
Background:
- Abdominal pain is a primary symptom in functional bowel disorders (FBDs).
- Accurate classification of FBD subtypes is crucial for effective patient management.
- The Rome III criteria define various FBD subtypes based on symptom profiles.
Purpose of the Study:
- To investigate and characterize the specific abdominal pain locations associated with different subtypes of functional bowel disorders.
- To establish correlations between predominant pain sites and FBD classifications.
Main Methods:
- A cohort of 584 patients with FBDs was analyzed.
- Data collected included stool form, abdominal pain location across nine segments, and pain intensity.
- Logistic regression analysis was employed to link pain sites with FBD subtypes.
Main Results:
- Irritable bowel syndrome with constipation correlated with left flank pain.
- Functional constipation was associated with right hypochondrium pain.
- IBS with alternating constipation and diarrhea presented with right flank pain; unsubtyped IBS with hypogastric pain; functional abdominal pain syndrome with lower right flank pain.
Conclusions:
- Predominant pain sites are associated with specific FBD subtypes.
- These findings support the development of new criteria for identifying homogeneous groups within non-diarrheic FBDs.
- Characteristic pain locations may aid in refining FBD diagnosis and classification.
Related Concept Videos
01:19Abdominal Regions and Quadrants
To promote clear communication, for instance, about the location of a patient's abdominal pain or a suspicious mass, anatomists and clinicians typically use imaginary lines to categorize the abdominopelvic cavity into either four quadrants or nine regions to identify organs in the cavity.
The simpler quadrants approach, which is more commonly used in medicine, subdivides the cavity with one horizontal and one vertical line that intersects at the patient's umbilicus (navel). The four quadrants...
The simpler quadrants approach, which is more commonly used in medicine, subdivides the cavity with one horizontal and one vertical line that intersects at the patient's umbilicus (navel). The four quadrants...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:23Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
01:22Appendicitis-I: Introduction
The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...